Lithium shows promise in treating autism-related symptoms in mouse study

byInstitute for Basic ScienceLithium restored microcephaly, abnormal synaptic function, and communication issues in mice with Dyrk1a deficiency, a gene associated with autism and Dyrk1a syndrome

Updated on: January 18,2025

Lithium shows promise in treating autism-related symptoms in mouse study

byInstitute for Basic ScienceLithium restored microcephaly, abnormal synaptic function, and communication issues in mice with Dyrk1a deficiency, a gene associated with autism and Dyrk1a syndrome

Updated on:January 18,2025

Blood-based biomarkers for Alzheimer's disease: Study in China

by Science China PressA total of 817 participants were recruited to evaluate potential alterations in blood-based biomarkers for AD among different clinical groups, including AD dementia, non-AD

Updated on: April 08,2024

Blood-based biomarkers for Alzheimer's disease: Study in China

by Science China PressA total of 817 participants were recruited to evaluate potential alterations in blood-based biomarkers for AD among different clinical groups, including AD dementia, non-AD

Updated on:April 08,2024

Can the healthy brain offer clues to curing Alzheimer's?

by The ConversationImage of brain with regions of the medial temporal lobe colour-coded"Have you cured Alzheimer's disease yet?"This is a common question people ask when they discov

Updated on: June 24,2024

Can the healthy brain offer clues to curing Alzheimer's?

by The ConversationImage of brain with regions of the medial temporal lobe colour-coded"Have you cured Alzheimer's disease yet?"This is a common question people ask when they discov

Updated on:June 24,2024

Depression symptoms in Alzheimer's could be signs for cognitive decline

by Massachusetts General HospitalCredit: CC0 Public DomainBOSTON -Increasingly, Alzheimer's disease (AD) research has focused on the preclinical stage, when people have biological evidence of

Updated on: April 18,2024

Depression symptoms in Alzheimer's could be signs for cognitive decline

by Massachusetts General HospitalCredit: CC0 Public DomainBOSTON -Increasingly, Alzheimer's disease (AD) research has focused on the preclinical stage, when people have biological evidence of

Updated on:April 18,2024

Patients with Alzheimer's dementia and related disorders who also have delirium incur greater health care costs

by Brigham and Women's HospitalCredit: Pixabay/CC0 Public DomainAlzheimer's Dementia and Related Disorders (ADRD) affects upwards of 5 million people in the United States, with no known t

Updated on: June 07,2024

Patients with Alzheimer's dementia and related disorders who also have delirium incur greater health care costs

by Brigham and Women's HospitalCredit: Pixabay/CC0 Public DomainAlzheimer's Dementia and Related Disorders (ADRD) affects upwards of 5 million people in the United States, with no known t

Updated on:June 07,2024

Most with intractable Meniere disease experience symptom relief

by Elana GotkineMost patients with intractable Meniere disease (MD) experience symptom relief over time, according to a study published online Oct. 23 inFrontiers in Neurology.F.R. Gerritsen, fr

Updated on: December 23,2024

Most with intractable Meniere disease experience symptom relief

by Elana GotkineMost patients with intractable Meniere disease (MD) experience symptom relief over time, according to a study published online Oct. 23 inFrontiers in Neurology.F.R. Gerritsen, fr

Updated on:December 23,2024

Alzheimer's drug may help maintain mitochondrial function in muscles as it slows cognitive decline

by American Physiological SocietyCredit: Pixabay/CC0 Public DomainA common treatment for Alzheimer's disease may help people with the earliest stages of the disease maintain mitochondrial fun

Updated on: April 23,2024

Alzheimer's drug may help maintain mitochondrial function in muscles as it slows cognitive decline

by American Physiological SocietyCredit: Pixabay/CC0 Public DomainA common treatment for Alzheimer's disease may help people with the earliest stages of the disease maintain mitochondrial fun

Updated on:April 23,2024

Reducing early brain inflammation could slow Alzheimer's progression

by Experimental BiologyThis fluorescent photomicrograph shows astrocytes (green) and neurons (pink) in the dentate gyrus of rat hippocampus. Credit: Giorgia Menegoni, Sapienza, University of RomeIn a

Updated on: June 20,2024

Reducing early brain inflammation could slow Alzheimer's progression

by Experimental BiologyThis fluorescent photomicrograph shows astrocytes (green) and neurons (pink) in the dentate gyrus of rat hippocampus. Credit: Giorgia Menegoni, Sapienza, University of RomeIn a

Updated on:June 20,2024

In quiet debut, Alzheimer's drug finds questions, skepticism

by Tom MurphyThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. The first new Alzheimer's treatment in more than 20 years was hailed as a breakt

Updated on: April 23,2024

In quiet debut, Alzheimer's drug finds questions, skepticism

by Tom MurphyThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. The first new Alzheimer's treatment in more than 20 years was hailed as a breakt

Updated on:April 23,2024

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39

Updated on: May 20,2024

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39

Updated on:May 20,2024

Scientists reveal structures of neurotransmitter transporter

bySt. Jude Children's Research HospitalCorresponding author Chia-Hsueh Lee, Ph.D., co-first author Shabareesh Pidathala, Ph.D., and co-first author Yaxin Dai, Ph.D. with maps of neurotransmi

Updated on: January 12,2024

Scientists reveal structures of neurotransmitter transporter

bySt. Jude Children's Research HospitalCorresponding author Chia-Hsueh Lee, Ph.D., co-first author Shabareesh Pidathala, Ph.D., and co-first author Yaxin Dai, Ph.D. with maps of neurotransmi

Updated on:January 12,2024

Bench-to-bedside drug design could lead to new Alzheimer's disease treatments

by University of GlasgowCredit: CC0 Public DomainAn international team of scientists and pharmaceutical collaborators has made a breakthrough "bench to bedside" discovery, ten years in

Updated on: May 13,2024

Bench-to-bedside drug design could lead to new Alzheimer's disease treatments

by University of GlasgowCredit: CC0 Public DomainAn international team of scientists and pharmaceutical collaborators has made a breakthrough "bench to bedside" discovery, ten years in

Updated on:May 13,2024